Compare Godaddy Inc (GDDY) vs Philip Morris International Inc. (PM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs Philip Morris International Inc. — how do they compare? Godaddy Inc trades at $102.04 (market cap $13.07B), while Philip Morris International Inc. trades at $200.2 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 23.9× Godaddy Inc's market cap, and Philip Morris International Inc. pays a 3.19% dividend while Godaddy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 65 Days and Philip Morris International Inc. for 85 Days on average.
| GDDY | PM | |
|---|---|---|
Market Cap | $13.07B | $312.50B |
Volume | 1,831,274 | 5,517,172 |
Sector | Technology | Consumer Staples |
52-Week High | $135.18 | $200.50 |
52-Week Low | $75.07 | $144.33 |
Typical Hold Time | 65 Days | 85 Days |
Enterprise Value | $15.75B | $355.62B |
Dividend Yield | — | 3.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $97.21, down 0.99% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company maintains strong fundamentals with consistent earnings beats, posting $4.95B revenue and $875M net income in 2025. Valuation metrics appear reasonable with P/E of 14.44 and P/S of 2.58. However, the stock faces significant headwinds from multiple securities class action lawsuits alleging misrepresentation of domain contract terms, creating investor uncertainty despite positive financial performance.
The outlook remains mixed with strong operational performance offset by legal risks. Analyst consensus leans bullish with 57.9% buy ratings and $96.20 price target, but the numerous securities lawsuits represent material downside risk. Investors should weigh the company's solid profitability and cash flow generation against potential legal liabilities and reputational damage from the ongoing litigation.
Philip Morris International (PM) trades at $200.5, up 5.3% over 24 hours, with a bullish technical signal and strong earnings beats in Q1 and Q2 2026. The company shows robust fundamentals with 2025 revenue of $40.65B and net income of $11.35B, supported by a 67.48% gross margin. Recent news highlights expansion of smoke-free products like ZYN and IQOS, now over 40% of revenue, driving growth amid industry shifts.
Outlook is positive with analyst consensus at Buy (68%) and a $212.17 price target, though elevated P/E of 26.46 and regulatory risks in tobacco remain concerns. Earnings growth and smoke-free product adoption are key catalysts, but investors should monitor debt levels and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
